Enriquecimiento e identificación de células fetales en sangre materna y ligandos para tal uso

The present invention relates to enrichment and/or identification of fetal cells of a maternal blood sample using fetal cell specific ligands and/or fetal cell specific hybridization probes wherein the ligand or probes are directed to an endothelial/mesenchymal marker, e.g. CD105, CD146 or CD141, in...

Full description

Saved in:
Bibliographic Details
Main Authors BRINCH, Marie, CHRISTENSEN, Britta, ECKELT, Andreas, KØLVRAA, Steen, SINGH, Ripudaman, HATT, Lotte
Format Patent
LanguageSpanish
Published 16.11.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to enrichment and/or identification of fetal cells of a maternal blood sample using fetal cell specific ligands and/or fetal cell specific hybridization probes wherein the ligand or probes are directed to an endothelial/mesenchymal marker, e.g. CD105, CD146 or CD141, in a first round of enrichment and the ligand or probes, in a second round of enrichment, are directed to an epithelial marker, e.g. a cytokeratin, such as CK7, CK8, CK18 or CK19. Enriched or identified fetal cells may be subjected to steps of detection or diagnosis, wherefore the present invention enables non-invasive 5 prenatal diagnostics.
Bibliography:Application Number: ES20110785308T